Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Orpea draws €200m from new financing

Headline grabbing French nursing home giant Orpea has made a drawdown of €200m from new financing, as it tries to restructure after a difficult 18 months.

India continues to boom

India is continuing to buck the global trend of slow deal activity in 2023, with multiple major health care services deals in process.

Ribera CEO positive about Alzira future

Last week we reported how the result of the recent elections in Valencia means the Alzira model may yet survive in Spain. We speak to the CEO of the hospital group which pioneered that model to see what he thinks might happen next.

GenesisCare in the US files for bankruptcy

GenesisCare, the radiotherapy group with operations in the US, UK, Australia and Spain, has filed for voluntary reorganisation under chapter 11 of the US bankruptcy code and will look to sell off its US assets. HBI speaks to an advisory source to find out more.

Valencian elections hint at the resurrection of Alzira

The leftist government of Valencia has been routed in regional elections. Could this mean a restoration of the out-of-favour Alzira model of public-private partnership (PPP) hospitals? HBI speak to a consultant source to find out more.

Low key Latvia sale kicks off Orpea refocusing

Last week, French nursing home operator Orpea initiated the start of the partial sale of its €1.2bn real estate portfolio, commencing with its Latvian presence - a singular retirement home in Riva. This low key sale marks the first small step in a major three-year plan to refocus its geographies. HBI speaks to a market expert to find out more.

Changes at the top of Runwood Homes

Three members of the senior leadership team at UK nursing home operator Runwood Homes departed the firm last month. COO Lorraine McGarry-Wall, CFO Phillip Thomas, and CEO Jeremy Richardson had all been appointed as directors of the company within the last 12 months. 

Dutch competition authority gets reined in again

The Netherlands’ activist competition authority has been reined in again. The acquisition of dermatology specialist Mauritskliniek by hospital group Bergman Clinics is no longer barred, after another reversal by a judge. However, the decision is moot, as Mauritskliniek has already been bought by German cosmetic surgery provider Corius Gruppe.

Find Us